TriMark Publications (http://www.trimarkpublications.com/conferences/
The TriMark Molecular Diagnostics 2008 Conference has been organized to provide a critical examination of the molecular diagnostics industry, as well as to provide insight from key
industry leaders concerning cutting-edge molecular diagnostics technology. This conference will also provide an integral forum for leaders in molecular diagnostics, in vitro diagnostics
and laboratories to share ideas, network with other delegates and advance understanding of the potential of new molecular diagnostics technologies. Speakers will include:
- Kaiser Aziz, Ph.D., U.S. Food and Drug Administration (retired)
- Joseph Dooley, Ph.D., DABCC, FACB, Chief Executive Officer, TriMark Publications
- Helen Fernandes, Ph.D., Department of Pathology and Laboratory Medicine, New Jersey School of Medicine - University Hospital
- Harry Glorikian, Managing Partner, Scientia Advisors
- Graham Lidgard, Ph.D., Senior VP Research and Development, Nanogen
- Gwen McMillian, Ph.D., DABCC, University of Utah, ARUP Laboratory
- David Okrongly, Ph.D., Senior VP Molecular Diagnostics, Siemens
Who Should Attend:
- Molecular diagnostics companies.
- In vitro diagnostic companies.
- Biotechnology companies.
- Medical devices manufacturers.
- Molecular diagnostic laboratorians
Leaders from the Following Areas Will Greatly Benefit from Attending:
- Laboratory leaders.
- Hospital CFOs and CSOs.
- Molecular diagnostics and in vitro diagnostic companies.
- Business development.
- Strategic planning and development.
- Technology development.
- Marketing.
- Research and development.
Key Themes:
- A critical examination of key emerging technologies applicability to molecular diagnostics.
- Formation of successful alliances.
- Partnering of emerging technologies with molecular diagnostics.
- Transitioning from laboratory in vitro diagnostics to molecular diagnostics.
Questions Answered in the TriMark Conference:
- What will the molecular diagnostics market be worth by the end of the decade
- Which market segments will drive molecular diagnostics market growth
- Which new technologies will reach the molecular diagnostics market in the next 2-3 years
- How is technology innovation impacting the dynamics and ownership of the molecular diagnostics industry
- What are the key challenges in gaining acceptance of new technologies by users, payers and regulators
- How is technology innovation facilitating the transition of molecular diagnostics testing into standard healthcare practice
Top Five Reasons To Attend the TriMark Conference:
- Discover the molecular diagnostics sectors with the greatest prospective growth, ensuring you can successfully align your future strategies with predicted
success.
- Evaluate the competitive dynamics of the molecular diagnostics market and understand the changing relationship between IVD companies and the molecular diagnostics
testing sector.
- Identify the key players in the molecular diagnostics market, recognize lucrative partnering opportunities and benchmark your strategies against the leading
players.
- Assess opportunities and challenges faced by diagnostic companies in gaining acceptance of innovative technologies by payers, regulators and users.
- Understand the factors driving growth of the molecular diagnostics market, which represents over 30% of global in vitro diagnostics sales.
Registration Fees for the Conference:
- Early-Bird Registration Fee is $750 until February 29, 2008.
- Standard Registration Fee is $995 on and after March 1, 2008.
- At-the-Door Fee $1,295 on March 31, 2008 (subject to seating availability).
Register at http://www.trimarkpublications.com/conferences/
Important Notice
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may
differ materially.
Contact
TriMark Publications, LLC
212.265.9877